You are here
Performance Measures
ACP is working actively in the field of performance measurement because we recognize its importance in the changing health care environment and want to shape its impact on Internal Medicine. The Performance Measurement Committee oversees the College's activities in this area.
The Performance Measurement Committee applies criteria to assess the validity of performance measures for healthcare. This tool has been created to help you filter the reviewed performance measures.
Recent Measure Reviews
- Group/Practice
- Individual Clinician
Comprehensive Diabetes Care: Medical Attention for Nephropathy
The percentage of patients 18-75 years of age with diabetes (type 1 and type 2) who received a nephropathy screening or monitoring test or had evidence of nephropathy during the measurement year.
Date Reviewed: March 29, 2019
- Group/Practice
- Individual Clinician
Zoster (Shingles) Vaccination
The percentage of patients 50 years of age and older who have a Varicella Zoster (shingles) vaccination.
Date Reviewed: November 4, 2018
- Group/Practice
- Health Plan
- Individual Clinician
- Population: Regional and State
Adherence to Antipsychotic Medications for Individuals with Schizophrenia
Percentage of individuals at least 18 years of age as of the beginning of the measurement period with schizophrenia or schizoaffective disorder who had at least two prescription drug claims for antipsychotic medications and had a Proportion of Days Covered (PDC) of at least 0.8 for antipsychotic medications during the measurement period (12 consecutive months).
Date Reviewed: November 4, 2018
- Group/Practice
- Individual Clinician
Tuberculosis (TB) Prevention for Patients with Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis Patients on a Biological Immune Response Modifier
Percentage of patients whose providers are ensuring active tuberculosis prevention either through yearly negative standard tuberculosis screening tests or are reviewing the patient’s history to determine if they have had appropriate management for a recent or prior positive test.
Date Reviewed: November 4, 2018
- Group/Practice
- Health Plan
- Individual Clinician
Continuity of Pharmacotherapy for Opioid Use Disorder (OUD)
Percentage of adults 18-64 years of age with pharmacotherapy for opioid use disorder (OUD) who have at least 180 days of continuous treatment.
Date Reviewed: November 4, 2018
- Group/Practice
- Individual Clinician
Communication with the Physician or Other Clinician Managing On-Going Care Post-Fracture for Men and Women Aged 50 Years and Older
Percentage of adults 50 years and older treated for a fracture with documentation of communication, between the physician treating the fracture and the physician or other clinician managing the patient’s on-going care, that a fracture occurred and that the patient was or should be considered for osteoporosis treatment or testing. This measure is reported by the physician who treats the fracture and who therefore is held accountable for the communication.
Date Reviewed: November 4, 2018
- Group/Practice
- Individual Clinician
Appropriate Use of DXA Scans in Women Under 65 Years Who do not Meet the Risk Factor Profile for Osteoporosis
Percentage of female patients aged 50 to 64 without select risk factors for osteoporotic fracture who received an order for a dual-energy x-ray absorptiometry (DXA) scan during the measurement period.
Date Reviewed: November 4, 2018
- Group/Practice
- Individual Clinician
Sleep Apnea: Severity Assessment at Initial Diagnosis
Percentage of patients aged 18 years and older with a diagnosis of obstructive sleep apnea who had an apnea hypopnea index (AHI) or a respiratory disturbance index (RDI) measured at the time of initial diagnosis.
Date Reviewed: November 4, 2018
- Group/Practice
- Individual Clinician
Sleep Apnea: Assessment of Adherence to Positive Airway Pressure Therapy
Percentage of visits for patients aged 18 years and older with a diagnosis of obstructive sleep apnea who were prescribed positive airway pressure therapy who had documentation that adherence to positive airway pressure therapy was objectively measured.
Date Reviewed: November 4, 2018
- Group/Practice
- Individual Clinician
Ischemic Vascular Disease: Use of Aspirin or Another Platelet
The percentage of patients 18-75 years of age who had a diagnosis of ischemic vascular disease (IVD) and were on daily aspirin or anti-platelet medication, unless allowed contraindications or exceptions are present.
Date Reviewed: November 4, 2018
- Group/Practice
- Individual Clinician
Assessment of Hepatitis B Virus (HBV) Status before Initiating Anti-Tumor Necrosis Factor (TNF) Therapy
Percentage of patients aged 18 years and older with a diagnosis of inflammatory bowel disease (IBD) who had Hepatitis B Virus (HBV) status assessed and results interpreted within one year prior to receiving a first course of anti-TNF (tumor necrosis factor) therapy.
Date Reviewed: November 4, 2018
- Group/Practice
- Individual Clinician
HIV Infection Screening
Percentage of patients 15-65 years of age who were tested at least once for HIV.
Date Reviewed: November 4, 2018
- Facility
- Group/Practice
- Individual Clinician
HIV: Viral Load Suppression
Percentage of patients, regardless of age, with a diagnosis of HIV with a HIV viral load less than 200 copies/mL at last HIV viral load test during the measurement year. A medical visit is any visit in an outpatient/ambulatory care setting with a nurse practitioner, physician, and/or a physician assistant who provides comprehensive HIV care.
Date Reviewed: November 4, 2018
- Group/Practice
- Health Plan
- Individual Clinician
Medical Attention for Nephropathy
The percentage of patients 18-75 years of age with diabetes (type 1 and type 2) who received a nephropathy screening or monitoring test or had evidence of nephropathy during the measurement year.
Date Reviewed: November 4, 2018
- Group/Practice
- Health Plan
- Individual Clinician
Diabetes: Eye Exam
The percentage of patients 18-75 years of age with diabetes (type 1 and type 2) who had an eye exam (retinal) performed.
Date Reviewed: November 4, 2018
- Group/Practice
- Individual Clinician
Angiotensin Converting Enzyme-Inhibitor (ACE-I) or Angiotensin Receptor Blocker (ARB) Therapy--Diabetes of LVSD (LVEF <40%)
Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period who also have diabetes OR a current or prior Left Ventricular Ejection Fraction (LVEF) < 40% who were prescribed ACE inhibitor or ARB therapy.
Date Reviewed: November 4, 2018
- Individual Clinician
Age Appropriate Screening Colonoscopy
The percentage of patients greater than 85 years of age who received a screening colonoscopy from January 1 to December 31.
Date Reviewed: November 4, 2018
- Group/Practice
- Individual Clinician
Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk Patients
Percentage of patients aged 50 years to 75 years receiving a screening colonoscopy without biopsy or polypectomy who had a recommended follow-up interval of at least 10 years for repeat colonoscopy documented in their colonoscopy report.
Date Reviewed: November 4, 2018
- Health Plan
- Individual Clinician
- Integrated Delivery System
Breast Cancer Screening
The percentage of women 50-74 years of age who had a mammogram to screen for breast cancer.
Date Reviewed: November 4, 2018